Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:

Abroad (travel likely)Recruiting

Conditions

Gliomas Harboring IDH1 and/or IDH2 Mutations · Glioma Glioblastoma Multiforme · Glioma of Brainstem · Glioma, Diffuse Midline, H3K27M-mutant · Glioma : Oligodendroglioma or Astrocytoma · Gliomas

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Xiangya Hospital of Central South University, Changsha, Hunan, China
Contact: Study coordinator (Xuan Gong, MD.) · gong.xuan@csu.edu.cn · 0086-731-8975-3037
Contact: Study coordinator (Shuwen Kuang, MD.) · 228102171@csu.edu.cn · 0086-13367494221

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations

Gliomas Harboring IDH1 and/or IDH2 Mutations

Abroad (travel likely)RecruitingPHASE1

Shanghai, China